Current Challenges and Advances in Diabetic Retinopathy
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 4719
Special Issue Editor
Special Issue Information
Dear Colleagues,
The area of diabetes eye disease is on the move. Important insights have been gained in recent years concerning the pathophysiology, risk-dependent early detection and therapeutic strategies of diabetic retinopathy.
There is still great potential to improve interdisciplinary cooperation and research. Retinopathy is indeed mentioned as an important microvascular complication, but the methodical recording of clinical endpoints and objective documentation within large diabetological trials is still in its infancy. The strong specialisation of ophthalmology may contribute to the fact that some natural scientists, internists and endocrinologists shy away from cooperation between different specialist groups.
The present Special Issue should encourage the presentation of new concepts and steps towards a better understanding and clinical care:
- There is great interest and need to overcome the limitations of old rodent experiments ‘generation streptozotocin’ and to gain clinical insights into diabetes drugs and influencing factors by new models;
- Important technical developments make it possible to map the pathophysiological significance of inflammation, neurodegeneration and hypoxia/vasculopathy and to integrate them into new classifications. Among the numerous innovations are optical coherence tomography (structural and angiographic/OCT-A), automatic image and vessel analysis via neural networks, analysis of large data and ultrawide-angle imaging;
- Risk stratification and telemedicine are frequently used buzzwords. What is needed, however, is a content-related examination of the concrete implementation in everyday life. The agreement of patient autonomy and data protection, the integration of fundus photography into other ophthalmic care, the preservation of a speaking medicine and the development of new ways of patient education and motivation should be in the focus;
- After the remarkable success of anti-VEGF therapy, the question of alternative or supporting treatment strategies arises.
The present Special Issue is intended to take up technical innovations, the digital revolution, molecular–biological screws and the detection/therapy of retinopathy in order to lead scientists from different disciplines to a dialogue. You are kindly requested to address one of the most relevant problems of the major widespread diseases. The number one concern of people with diabetes is loss of sight. In summary, all manuscripts with an impact on the development of new diagnostic or therapeutic approaches and clinical care of diabetic retinopathy are highly welcome.
Prof. Dr. Focke Ziemssen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- preclinical models of diabetic retinopathy
- teleophthalmology
- patient utilisation
- neuronal networks/artificial intelligence
- diabetic macular edema
- treatment strategies
- motivation work
- digital tools
- risk factors
- retinal imaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
